Tabib, Tracy
Huang, Mengqi http://orcid.org/0000-0002-1675-8575
Morse, Nina
Papazoglou, Anna
Behera, Rithika
Jia, Minxue
Bulik, Melissa
Monier, Daisy E.
Benos, Panayiotis V. http://orcid.org/0000-0003-3172-3132
Chen, Wei http://orcid.org/0000-0001-7196-8703
Domsic, Robyn
Lafyatis, Robert http://orcid.org/0000-0002-9398-5034
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R61AR076819, P50AR060780)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Article History
Received: 15 October 2019
Accepted: 11 June 2021
First Online: 19 July 2021
Competing interests
: R.L. has served as a consultant for Pfizer, Bristol Myers Squibb, Boehringer-Ingleheim, Formation, Sanofi, Boehringer-Mannheim, Merck, and Genentech/Roche, and holds or recently had research grants from Corbus, Formation, Moderna, Regeneron, Pfizer, and Kiniksa. R.D. has worked as a consultant for Eicos Sciences Inc. The remaining authors declare no competing interests.